When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NTRA - Studies underway on Natera test in colorectal cancer
Natera Inc.
Molecular testing services provider Natera (NTRA+1.3%) announces the commencement of enrollment in two clinical trials, CIRCULATE-Japan and BESPOKE CRC, evaluating clinical outcomes of its Signatera molecular residual disease (MRD) test in patients with resectable (Stages II - IV) colorectal cancer (CRC).
More news on: Natera, Inc., Healthcare stocks news, Stocks on the move,